Information Matrix

We've considered cancer and its relationship to aging on a number of previous occasions. Studies published in the British Journal of Cancer in 2011 and 2018 concluded that around 40% of cases are attributable to known modifiable lifestyle and environmental factors, which is a substantial minority.

When we previously discussed the progress of immunotherapy within cancer treatment, some of the most exciting results were in the field of leukaemia and melanoma, with progress in other solid cancers lagging somewhat behind.

Drug molecules, without special intervention, don't apply only where we want them to. Indeed, late last year this fact landed pharmaceutical giant Reckitt Benckiser in trouble with the Australian regulator.

In 2013, cancers represented more than one third of the top-fifteen causes of all-age mortality in the UK, irrespective of gender. Despite intensive efforts, for some cancers survival rates have scarcely improved for decades.